Conference Archive
A
C
I
M
S
- School of Breast Oncology
- St. Gallen International Breast Cancer Conference
- State of the Science Summit on A Summer of Progress: Updates from ASCO
- State of the Science Summit on Advanced NSCLC
- State of the Science Summit on Breast Cancer
- State of the Science Summit on GI Cancers in Newport Beach
- State of the Science Summit on GI Malignancies
- State of the Science Summit on Genitourinary Cancers
- State of the Science Summit on Genitourinary Cancers in Nashville
- State of the Science Summit on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer
- State of the Science Summit on Hematologic Malignancies
- State of the Science Summit on Hematologic Malignancies
- State of the Science Summit on Hematologic Malignancies in Chicago
- State of the Science Summit on Hematologic Malignancies in Clayton
- State of the Science Summit on Hematologic Malignancies in Cleveland
- State of the Science Summit on Melanoma and Immuno-Oncology
- State of the Science Summit on Multiple Myeloma and Myeloproliferative Neoplasms
- State of the Science Summit on Prostate Cancer
- State of the Science Summit on Treatment Options in Ovarian Cancer
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5